Inflammasome animation.

Inflazome, a biotech company developing new drugs to block harmful inflammation, has secured further investment of $63 million.

28 November 2018
Dr Kate Schroder, Deputy Director, IMB Centre for Inflammation Research

Inflazome Ltd, a company founded on research from The University of Queensland (UQ) and Trinity College Dublin, has closed a Series A financing round of up to €15 million (A$22 million).

12 September 2016

Researchers have unlocked secrets of our ancient immune system in a major scientific advance that could help scientists and clinicians in the global fight against disease.

24 June 2016
Associate Professor Trent Woodruff

A University of Queensland research team has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research to target brain inflammation in people with Parkinson’s disease.

6 March 2015